Press-release for stocks for eli lilly and company

Prices are updated after-hours

Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

entities : Eli lilly and company crawled time : 18:00

save search

Global Antidiabetics Market 10 Year Forecast Report 2024-2034, by Product Type, by Application, by Distribution Channel and Region
Published: 2024-03-13 (Crawled : 18:00) - prnewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M

|

Health Technology

| -7.83% | O: -0.64% H: 0.94% C: -0.56%
JNJ | News | $145.74 0.67% 0.0% 9.3M

|

Health Technology

| -10.31% | O: 0.66% H: 0.0% C: 0.0%
LLY | $745.95 -0.64% -0.1% 1.7M

|

Health Technology

| -0.55% | O: 0.27% H: 0.5% C: 0.11%
ABT | News | $105.27 -0.6% -0.15% 7.3M

|

Health Technology

| -10.19% | O: 0.41% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M

|

Health Technology

| -4.61% | O: -0.04% H: 0.0% C: 0.0%
report distribution year global market

United States Pharmaceuticals Market Size to Surpass US$ 1,068.02 Billion by 2030 | Exhibiting a CAGR of 8.6% Says CoherentMI
Published: 2024-02-22 (Crawled : 18:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K

|

Health Technology

| -8.97% | O: 0.37% H: 0.58% C: 0.58%
NVS | $92.57 -0.55% 0.0% 910K

|

Health Technology

| -9.46% | O: 0.89% H: 0.4% C: 0.17%
LLY | $745.95 -0.64% -0.1% 1.7M

|

Health Technology

| -2.45% | O: 0.57% H: 0.47% C: -0.58%
BMY | $48.3 0.96% -0.1% 11M

|

Health Technology

| -5.98% | O: 0.14% H: 1.01% C: 0.51%
ABBV | News | $164.66 0.25% -0.15% 4.5M

|

Health Technology

| -7.26% | O: 0.29% H: 0.93% C: 0.47%
SNY | News | $45.395 -1.55% -1.58% 4.4M

|

Health Technology

| -3.77% | O: 0.97% H: 0.0% C: 0.0%
GILD | News | $66.16 -1.15% -1.16% 6.4M

|

Health Technology

| -8.04% | O: 0.65% H: 1.35% C: 0.41%
AMGN | $262.77 -0.49% -0.49% 2M

|

Health Technology

| -6.4% | O: 0.47% H: 2.0% C: 0.93%
pharmaceuticals market

Global Cyclin-Dependent Kinase Inhibitor Drug Research Report 2023: Comprehensive Analysis of 45 Companies and 50+ Pipeline Drugs
Published: 2023-11-21 (Crawled : 18:00) - prnewswire.com
LLY | $745.95 -0.64% -0.1% 1.7M

|

Health Technology

| 25.54% | O: -0.44% H: 0.63% C: -0.05%
drug companies report pipeline research global

Alto Neuroscience Closes $45 Million in Oversubscribed Series C Financing
Published: 2023-11-21 (Crawled : 18:00) - biospace.com/
LLY | $745.95 -0.64% -0.1% 1.7M

|

Health Technology

| 25.63% | O: 0.07% H: 0.0% C: 0.0%
series

Kiyatec strengthens its leadership position with the addition of Mark Capone, former CEO of Myriad Genetics, as Strategic Advisor
Published: 2023-11-21 (Crawled : 18:00) - biospace.com/
LLY | $745.95 -0.64% -0.1% 1.7M

|

Health Technology

| 25.63% | O: 0.07% H: 0.0% C: 0.0%
ceo

Almirall Receives European Commission Approval of EBGLYSS® (lebrikizumab) for Moderate-to-Severe Atopic Dermatitis
Published: 2023-11-17 (Crawled : 18:00) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M

|

| -52.98% | O: -1.71% H: 0.0% C: 0.0%
LLY | $745.95 -0.64% -0.1% 1.7M

|

Health Technology

| 27.52% | O: 0.49% H: 0.0% C: 0.0%
ebglyss dermatitis approval

U.S. Food and Drug Administration (FDA) Approves FoundationOne®CDx as a Companion Diagnostic for Lilly’s Retevmo® (selpercatinib) for Certain Patients with Solid Tumors
Published: 2023-10-09 (Crawled : 18:00) - biospace.com/
LLY | $745.95 -0.64% -0.1% 1.7M

|

Health Technology

| 32.83% | O: -0.21% H: 2.8% C: 1.37%
foundationone drug diagnostic food tumors companion

Addressing Unmet Needs: Uveitis Market Report Provides Opportunities for Drug Developers
Published: 2023-08-03 (Crawled : 18:00) - prnewswire.com
LLY | $745.95 -0.64% -0.1% 1.7M

|

Health Technology

| 66.3% | O: -0.53% H: 0.0% C: 0.0%
drug report market

Allen Institute for Immunology partners with Lilly to better understand autoimmune disease
Published: 2023-07-18 (Crawled : 18:00) - biospace.com/
LLY | $745.95 -0.64% -0.1% 1.7M

|

Health Technology

| 67.9% | O: -0.04% H: 1.43% C: 0.95%
institute disease immunology

Lilly Announces Webcast to Provide Alzheimer's Disease Update at AAIC
Published: 2023-07-11 (Crawled : 18:00) - biospace.com/
LLY | $745.95 -0.64% -0.1% 1.7M

|

Health Technology

| 65.67% | O: -0.7% H: 0.12% C: -2.36%
disease update alzheimer's aaic

Sermonix Pharmaceuticals Announces Article Comparing ‘Traditional’ to ‘Just-in-Time’ Trial Enrollment Models Is Published in JCO Clinical Cancer Informatics
Published: 2023-06-26 (Crawled : 18:00) - biospace.com/
LLY | $745.95 -0.64% -0.1% 1.7M

|

Health Technology

| 63.62% | O: 1.4% H: 0.0% C: -2.69%
LGND | $72.61 -7.94% -8.62% 130K

|

Health Technology

| 7.91% | O: -0.3% H: 1.85% C: -0.84%
cancer pharmaceuticals trial

Lilly to present new research in the treatment of diabetes and obesity at the American Diabetes Association's® 83rd Scientific Sessions
Published: 2023-06-20 (Crawled : 18:00) - prnewswire.com
LLY | $745.95 -0.64% -0.1% 1.7M

|

Health Technology

| 67.69% | O: -0.41% H: 2.02% C: 1.37%
obesity sessions treatment research diabetes

Duchenne Muscular Dystrophy Drugs Global Market Report 2023: Sector to Reach $18.1 Billion by 2030 at a 42.5% CAGR
Published: 2023-05-03 (Crawled : 18:00) - prnewswire.com
PFE A | $25.39 -0.12% -0.12% 36M

|

Health Technology

| -33.89% | O: -0.73% H: 0.68% C: 0.16%
LLY | $745.95 -0.64% -0.1% 1.7M

|

Health Technology

| 74.12% | O: 0.06% H: 0.29% C: -0.7%
BMY | $48.3 0.96% -0.1% 11M

|

Health Technology

| -27.58% | O: -0.29% H: 1.19% C: 0.56%
PTCT | $24.71 -1.79% -1.82% 820K

|

Health Technology

| -54.59% | O: -0.38% H: 1.38% C: 1.2%
LXRX | News | $1.625 0.31% 0.31% 3.7M

|

Health Technology

| -40.88% | O: 2.19% H: 13.21% C: 10.0%
report reach global duchenne market

Global Biosimilars Business and Investment Opportunities 2023: Attractive Approval Numbers Present Fertile Ground for New Entrants
Published: 2023-04-18 (Crawled : 18:00) - prnewswire.com
LLY | $745.95 -0.64% -0.1% 1.7M

|

Health Technology

| 101.63% | O: 0.17% H: 0.34% C: -0.83%
CHRS | $1.99 -7.44% -8.04% 1.9M

|

Health Technology

| -73.88% | O: 0.73% H: 0.0% C: -1.45%
BIIB | $190.55 -0.84% -0.84% 1.5M

|

Health Technology

| -33.21% | O: 0.05% H: 0.77% C: 0.5%
business approval global

Onconova Therapeutics Appoints Drs. Peter Atadja and Trafford Clarke to its Board of Directors
Published: 2022-12-19 (Crawled : 18:00) - globenewswire.com
LLY | $745.95 -0.64% -0.1% 1.7M

|

Health Technology

| 109.84% | O: 0.2% H: 0.82% C: 0.32%
ONTX | $0.9953 -5.61% 1.3M

|

Health Technology

| 53.82% | O: 2.55% H: 7.5% C: 0.49%
therapeutics

Lilly and IABL Collaborate to Ensure Patient Access to High-Quality Affordable Insulin in Bangladesh
Published: 2023-02-13 (Crawled : 18:00) - biospace.com/
LLY | $745.95 -0.64% -0.1% 1.7M

|

Health Technology

| 117.54% | O: 0.39% H: 1.25% C: 1.13%
insulin

Smart Insulin Pens Market Size to Reach USD 302.1 Million in 2030 | Emergen Research
Published: 2023-02-06 (Crawled : 18:00) - prnewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M

|

Health Technology

| -8.96% | O: 0.61% H: 0.88% C: 0.33%
MDT | $79.19 0.14% 0.0% 6.1M

|

Health Technology

| -9.21% | O: -0.31% H: 0.08% C: -1.83%
LLY | $745.95 -0.64% -0.1% 1.7M

|

Health Technology

| 121.41% | O: 0.86% H: 0.42% C: -1.26%
SNY | News | $45.395 -1.55% -1.58% 4.4M

|

Health Technology

| 0.39% | O: -0.84% H: 0.0% C: 0.0%
research smart insulin market

Worldwide Monoclonal Antibodies Industry to 2033 - Rising mAb Therapy Applications for Targeted Therapies Drives Growth
Published: 2023-01-18 (Crawled : 18:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510

|

Health Technology

| 13.48% | O: 1.12% H: 0.0% C: -1.68%
SNYNF | News | $92.7 -2.18% 1.4K

|

Health Technology

| -7.09% | O: -2.5% H: 0.0% C: 0.0%
AZNCF | $140.15 -4.19% 560

|

Health Technology

| -5.79% | O: -1.16% H: 1.62% C: -0.54%
NVSEF | $93.6375 6.88% 82K

|

Health Technology

| 22.87% | O: 0.05% H: 0.0% C: 0.0%
VTRS | $11.11 0.09% 0.09% 3.5M

|

Health Technology

| -6.25% | O: -0.17% H: 0.25% C: -2.96%
TMO | News | $541.52 -1.05% 0.61% 2.1M

|

Health Technology

| -6.91% | O: 0.56% H: 0.97% C: -1.87%
NVO | $122.75 -1.43% 0.0% 2.8M

|

Health Technology

| -10.4% | O: 0.57% H: 0.84% C: -0.01%
NVS | $92.57 -0.55% 0.0% 910K

|

Health Technology

| 0.76% | O: 0.93% H: 0.01% C: -1.16%
JNJ | News | $145.74 0.67% 0.0% 9.3M

|

Health Technology

| -16.01% | O: -0.41% H: 0.2% C: -1.1%
GSK | $39.27 -0.83% 0.01% 2.2M

|

Health Technology

| 11.36% | O: -0.03% H: 0.17% C: -1.01%
LLY | $745.95 -0.64% -0.1% 1.7M

|

Health Technology

| 109.86% | O: -0.4% H: 0.75% C: -1.21%
ABT | News | $105.27 -0.6% -0.15% 7.3M

|

Health Technology

| -4.82% | O: -0.16% H: 0.33% C: -1.5%
SNY | News | $45.395 -1.55% -1.58% 4.4M

|

Health Technology

| -7.47% | O: -0.14% H: 0.0% C: 0.0%
BIIB | $190.55 -0.84% -0.84% 1.5M

|

Health Technology

| -32.61% | O: 0.34% H: 0.46% C: -2.45%
AZN | $68.36 -0.25% -0.25% 4M

|

Health Technology

| -3.5% | O: 1.36% H: 0.33% C: -1.13%
AMGN | $262.77 -0.49% -0.49% 2M

|

Health Technology

| -0.92% | O: 0.0% H: 0.41% C: -1.87%
therapy growth

Digital Diabetes Management Market Size to Reach USD 37.8 Billion in 2030 | Emergen Research
Published: 2022-12-21 (Crawled : 18:00) - prnewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M

|

Health Technology

| -5.79% | O: -0.15% H: 0.76% C: 0.38%
MDT | $79.19 0.14% 0.0% 6.1M

|

Health Technology

| 3.1% | O: 0.83% H: 0.81% C: -0.23%
LLY | $745.95 -0.64% -0.1% 1.7M

|

Health Technology

| 108.76% | O: 0.83% H: 2.22% C: 1.48%
ABT | News | $105.27 -0.6% -0.15% 7.3M

|

Health Technology

| 1.35% | O: 0.56% H: 1.21% C: 0.98%
TNDM | $30.92 -2.61% -2.68% 1.1M

|

Health Technology

| -23.57% | O: 0.75% H: 2.25% C: 1.6%
PODD | $164.71 -0.93% -0.94% 590K

|

Health Technology

| -44.31% | O: 0.49% H: 1.16% C: 0.49%
DXCM | $134.3 0.33% 0.33% 2.1M

|

Health Technology

| 20.65% | O: 0.64% H: 1.98% C: 0.78%
management research diabetes market

Cancer Monoclonal Antibodies Market Report 2022: Rising Preference for Personalized Medicines Provides Boost to Sector
Published: 2022-11-04 (Crawled : 18:00) - prnewswire.com
GNMSF | $281.02 3.83% 210

|

Health Technology

| -29.16% | O: -2.57% H: 3.43% C: 2.04%
NVSEF | $93.6375 6.88% 82K

|

Health Technology

| 41.88% | O: 2.28% H: 0.0% C: 0.0%
NVS | $92.57 -0.55% 0.0% 910K

|

Health Technology

| 15.8% | O: 1.13% H: 0.63% C: 0.53%
JNJ | News | $145.74 0.67% 0.0% 9.3M

|

Health Technology

| -14.8% | O: 0.38% H: 0.0% C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M

|

Health Technology

| 20.58% | O: 1.25% H: 0.03% C: -0.78%
LLY | $745.95 -0.64% -0.1% 1.7M

|

Health Technology

| 107.58% | O: 0.97% H: 0.18% C: -2.13%
BMY | $48.3 0.96% -0.1% 11M

|

Health Technology

| -38.51% | O: 0.42% H: 0.59% C: -0.04%
ABBV | News | $164.66 0.25% -0.15% 4.5M

|

Health Technology

| 13.51% | O: 0.64% H: 0.16% C: -0.05%
GMAB | $28.32 -0.74% -0.74% 240K

|

Health Technology

| -27.5% | O: 0.58% H: 0.93% C: 0.93%
AMGN | $262.77 -0.49% -0.49% 2M

|

Health Technology

| 0.4% | O: -1.48% H: 2.81% C: 2.71%
report cancer market

← Previous
1
2
3
Next →

Gainers vs Losers

64%

36%

Top 10 Gainers

AGBA | News | $1.02 155.0% 57.94% 120M

|

ZCMD | $2.86 108.76% 52.1% 2.3M

|

Commercial Services

INVO | $1.555 104.6% 51.13% 5M

|

Health Technology

ISPC | $0.437 105.16% 49.53% 37M

|

Professional, Scientific, and T...

WLGS | News | $0.92 84.0% 45.65% 1.6M

|

OST | $0.499 21.38% 45.26% 1.9M

|

XPON | News | $3.1 60.62% 37.74% 17M

|

TIRX | $0.7 44.39% 30.74% 58M

|

BNTC | News | $6.92 44.17% 30.64% 3.5M

|

Health Technology

GGE | $0.035 19.86% 29.3% 64M

|

Your saved searches

Save your searches and get alerts when important news are released.